Bispecific Antibody Selection in Multiple Myeloma

Opinion
Video

Clinical insights on selecting the right bispecific antibody for the right patient and an overview of barriers seen in community practice.

Recent Videos
4 experts are featured in this series.
3 experts in this video
3 experts in this video
3 experts in this video
3 experts in this video
Using bispecific antibodies before or after CAR T-cell therapy in multiple myeloma is an area of education for community oncologists.
3 experts in this video
3 experts in this video
2 experts are featured in this series.
9 Experts are featured in this series.
Related Content